Please try another search
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:Avianca Holdings S.A. (AVH): This company that provides passenger and cargo air transportation services has seen the Zacks...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even...
Bausch Health (BHC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings...
BioTelemetry (BEAT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock...
In the past week, two Auto giants — Tesla, Inc. (NASDAQ:TSLA) and Autoliv, Inc. (NYSE:ALV) — announced their numbers for fourth-quarter 2018. The companies reported an earnings...
AeroVironment (AVAV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock...
Sanofi (PA:SASY) (NASDAQ:SNY) announced that a phase III study, evaluating its pipeline candidate — isatuximab — for the treatment of patients with relapsed/refractory multiple myeloma,...
Array BioPharma (ARRY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates...
Entertainment giant The Walt Disney Company (NYSE:DIS) registered growth last year. From revenues to net income to earnings per share, all improved on a year-over-year basis in fiscal...
Glatfelter (GLT) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.34 per share a year ago. These figures...
Cabot Corporation (NYSE:CBT) recorded net profit of $69 million or $1.14 per share in the first quarter of fiscal 2019 (ended Dec 31, 2018), against a net loss of $122 million or $1.98 in the...